$HRTX a company that already has two new drugs approved Sustol and Cinvanti provide assurances and value to the stock . HTX is having trouble but even with all that, the path to ultimately being approved will come. Be patient, this company is solid and the chances it gets bought out and succeeds are way higher than not.
  • 6
6 Likes